Robert J Laliberte

23 papers · 621 indexed citations

Standout Papers

Avelumab First-Line Maintenance for Advanced Urothelial Carcinoma: Results From the JAVELIN Bladder 100 Trial After ≥2 Years of Follow-Up (2023)
Thomas Powles, Se Hoon Park et al. Journal of Clinical Oncology

Immediate Impact

1 from Science/Nature 67 standout

Sub-graph 1 of 23

Citing Papers

High‐Strength Gelatin Hydrogel Scaffold with Drug Loading Remodels the Inflammatory Microenvironment to Enhance Osteoporotic Bone Repair

2025 Standout

Self-Cascaded Pyroptosis-STING Initiators for Catalytic Metalloimmunotherapy

2025 Standout

11 intermediate papers

Works of Robert J Laliberte being referenced

A phase II open-label study of recombinant human interleukin-12 in patients with stage IA, IB, or IIA mycosis fungoides

2006

Phase 1 Study of the Intravesical Administration of Recombinant Human Interleukin-12 in Patients With Recurrent Superficial Transitional Cell Carcinoma of the Bladder

2003

and 1 more

Author Peers

Author					Papers	Cites
Robert J Laliberte	253	234	134	135	23	621
Marco Greco	125	171	118	72	20	528
J.E. Byfield	181	196	120	41	29	556
Christian Teschendorf	72	220	181	73	28	608
Kazuei Hoshi	172	173	68	75	28	554
D. Paraïso	200	247	137	47	33	631
N C Armitage	155	453	89	40	33	652
Heran Deng	80	256	128	50	30	559
Yoshifumi Matsushita	103	180	301	303	20	657
Karakousis Cp	127	390	158	69	37	563
F. De Vita	72	401	200	53	35	680

All Works

Loading papers...